GB0119025D0 - Compounds and their therapeutic use - Google Patents

Compounds and their therapeutic use

Info

Publication number
GB0119025D0
GB0119025D0 GBGB0119025.5A GB0119025A GB0119025D0 GB 0119025 D0 GB0119025 D0 GB 0119025D0 GB 0119025 A GB0119025 A GB 0119025A GB 0119025 D0 GB0119025 D0 GB 0119025D0
Authority
GB
United Kingdom
Prior art keywords
compounds
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0119025.5A
Other versions
GB2378179A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantherix Ltd
Original Assignee
Pantherix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantherix Ltd filed Critical Pantherix Ltd
Priority to GB0119025A priority Critical patent/GB2378179A/en
Publication of GB0119025D0 publication Critical patent/GB0119025D0/en
Publication of GB2378179A publication Critical patent/GB2378179A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/42—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
GB0119025A 2001-08-03 2001-08-03 Aromatic sulfonamides and their use in treating bacterial diseases Withdrawn GB2378179A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0119025A GB2378179A (en) 2001-08-03 2001-08-03 Aromatic sulfonamides and their use in treating bacterial diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0119025A GB2378179A (en) 2001-08-03 2001-08-03 Aromatic sulfonamides and their use in treating bacterial diseases

Publications (2)

Publication Number Publication Date
GB0119025D0 true GB0119025D0 (en) 2001-09-26
GB2378179A GB2378179A (en) 2003-02-05

Family

ID=9919798

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0119025A Withdrawn GB2378179A (en) 2001-08-03 2001-08-03 Aromatic sulfonamides and their use in treating bacterial diseases

Country Status (1)

Country Link
GB (1) GB2378179A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115490618A (en) * 2022-09-02 2022-12-20 山东金城医药化工有限公司 Preparation method of sodium paeonol sulfonate

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404855A (en) * 2003-07-07 2005-02-16 Pantherix Ltd Arylcarboxylic acid derivatives and their therapeutic use
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
JPWO2006077901A1 (en) * 2005-01-20 2008-06-19 塩野義製薬株式会社 CTGF expression inhibitor
EP1979355B1 (en) 2006-01-30 2010-08-18 Irm Llc Spiro imidazole derivatives as ppar modulators
CN102786448B (en) * 2012-08-09 2014-03-12 深圳万乐药业有限公司 Method of synthesizing belinostat
CN105732444B (en) * 2016-03-28 2018-01-30 大连理工大学 A kind of his synthetic method of Baily department
WO2019232384A1 (en) * 2018-06-01 2019-12-05 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes
CN113767913B (en) * 2021-08-13 2022-10-14 上海应用技术大学 Application of 2- [ (4-chloro-3-nitrophenyl) sulfonamide ] benzoic acid in preparation of insect growth regulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID26773A (en) * 1998-07-08 2001-02-08 Aventis Pharma Gmbh SUBSTITUTED SULFUR IN N-ARILAMIDA SULFONYLAMINCARCYLIC ACID, PREPARATION, USE AND PREPARATION FOR THE MAKING OF DRUGS WHICH INCLUDE IT
MXPA02000123A (en) * 1999-06-24 2002-07-02 Smithkline Beecham Corp Macrophage scavenger receptor antagonists.
AR030911A1 (en) * 1999-07-20 2003-09-03 Smithkline Beecham Corp USE OF N-ARIL-2-SULFONAMIDOBENZAMIDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CHRONIC RENAL FAILURE AND PHARMACEUTICAL COMPOSITIONS
JP2003533477A (en) * 2000-05-12 2003-11-11 スミスクライン・ビーチャム・コーポレイション Phosphate transport inhibitors
AU2002213048A1 (en) * 2000-10-05 2002-04-15 Smith Kline Beecham Corporation Phosphate transport inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115490618A (en) * 2022-09-02 2022-12-20 山东金城医药化工有限公司 Preparation method of sodium paeonol sulfonate

Also Published As

Publication number Publication date
GB2378179A (en) 2003-02-05

Similar Documents

Publication Publication Date Title
GB0111872D0 (en) Therapeutic agents and methods
GB0105613D0 (en) Pharmaceutically effective compounds and their use
GB0108930D0 (en) Therapeutic agents
GB0207410D0 (en) Compounds and their therapeutic use
GB0119025D0 (en) Compounds and their therapeutic use
GB0111191D0 (en) Therapeutic agents
GB0018887D0 (en) Compound and their therapeutic use
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB2376943B (en) Compounds and their therapeutic use
GB0119370D0 (en) Therapeutic agent
GB0112237D0 (en) Compounds and their therapeutic use
GB0108982D0 (en) Therapeutic agents
GB0128122D0 (en) Therapeutic use
GB0123991D0 (en) New therapeutic use
GB0201615D0 (en) Compounds and their therapeutic use
GB0128512D0 (en) Compounds and their therapeutic use
GB0018885D0 (en) Compounds and their therapeutic use
GB0018888D0 (en) Compounds and their therapeutic use
GB0018886D0 (en) Compounds and their therapeutic use
GB0128128D0 (en) Therapeutic use
GB0128126D0 (en) Therapeutic use
GB0128123D0 (en) Therapeutic use
GB0128121D0 (en) Therapeutic use
GB0128090D0 (en) Therapeutic use
GB0128089D0 (en) Therapeutic use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)